Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 38
Filtrar
Más filtros

País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Dermatol Online J ; 20(5): 22639, 2014 May 16.
Artículo en Español | MEDLINE | ID: mdl-24852778

RESUMEN

Lichen planus pigmentosus is an uncommon variant of lichen planus that is characterized by the insidious onset of dark brown macules in sun-exposed areas and flexural folds. Superimposed linear lichen planus is an exceedingly rare disorder, but it has been found in both lichen planopilaris and lichen planus types. A 39-year-old woman is presented showing a segmental and linear lichen planus associated with non-segmental lesions meeting all criteria for the diagnosis of superimposed linear planus pigmentosus. The segmental lesions were always more pronounced.


Asunto(s)
Hiperpigmentación/patología , Liquen Plano/patología , Adulto , Femenino , Humanos , Hiperpigmentación/terapia , Liquen Plano/terapia , Terapia Ultravioleta
2.
Pediatr Dermatol ; 29(2): 166-8, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-22066938

RESUMEN

We performed a prospective study of 1,000 neonates investigated in the first 72 hours of life in the health area of Ferrol (northwest of Spain) to assess the prevalence of erythema toxicum neonatorum, the anatomical sites most frequently involved, the influence of different maternal and neonatal parameters, day of life of medical examination, and type of delivery (vaginal or Cesarean). Overall prevalence of erythema toxicum neonatorum was 16.7%. Lesions most frequently involved the trunk, buttocks, and proximal areas of limbs. A higher prevalence of this dermatosis was found in Caucasian newborns (p = 0.01) and those with higher birthweight (p < 0.05), greater gestational age (p < 0.05), vaginal delivery (p < 0.05), maternal age of <30 years (p = 0.28), and fewer than two previous pregnancies (p = 0.12).


Asunto(s)
Eritema/epidemiología , Enfermedades del Recién Nacido/epidemiología , Eritema/diagnóstico , Femenino , Edad Gestacional , Humanos , Recién Nacido , Enfermedades del Recién Nacido/diagnóstico , Masculino , Prevalencia , Estudios Prospectivos , Factores de Riesgo , España/epidemiología
3.
Pediatr Dermatol ; 29(3): 301-5, 2012.
Artículo en Inglés | MEDLINE | ID: mdl-21995277

RESUMEN

We performed a descriptive survey of 1,000 consecutive newborns cared for in the first 3 days of life in the health area of Ferrol (in northwest Spain) to assess the prevalence and most-frequent locations of oral cysts and milia and to study the influence of different maternal and neonatal parameters in the development of these lesions. Prevalence of palatal, gingival, and cutaneous cysts was 53.7%, 13.4%, and 16.6%, respectively. Milia were predominantly located on the cheeks, chin, and forehead. We found a frequent association between palatal and gingival cysts but not between oral cysts and milia. Neonatal factors such as sex, weight at birth, and gestational age can significantly influence the development of palatal and gingival cysts.


Asunto(s)
Quistes/epidemiología , Quiste Epidérmico/epidemiología , Enfermedades de las Encías/epidemiología , Hueso Paladar , Femenino , Humanos , Recién Nacido , Masculino , Prevalencia , España/epidemiología
4.
Pediatr Dermatol ; 28(6): 707-710, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21906144

RESUMEN

We report a 7-year-old boy with a past medical history of B-cell leukemia with dysmorphic features, including cleft palate, hypotrichosis with trichorrhexis nodosa, hypohidrosis, oligodontia, and ridging of nails. A heterozygous germline mutation, Ala111Thr, in the p63 gene was detected in the boy and in his mother, who had no clinical expression. This case emphasizes the spectrum of different phenotypical manifestations of mutations in the p63 gene and underlines the possible role of this gene as a tumor suppressor.


Asunto(s)
Displasia Ectodérmica/genética , Heterocigoto , Leucemia de Células B/genética , Mutación Puntual , Factores de Transcripción/genética , Proteínas Supresoras de Tumor/genética , Adulto , Niño , Labio Leporino/genética , Fisura del Paladar/genética , Femenino , Mutación de Línea Germinal , Humanos , Masculino
5.
Cutis ; 87(6): 287-8, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21838085

RESUMEN

Onycholysis is the distal and/or lateral separation of the nail from the nail bed. Although it can be idiopathic, there are several factors associated with the development of this condition. Ischemia is recognized as one of the possible causes, but this relationship has been poorly described in the literature. We report a case of onycholysis with a striking clinical picture and discuss the role of ischemia in the development of the lesions.


Asunto(s)
Mano/irrigación sanguínea , Onicólisis/diagnóstico , Anciano , Diagnóstico Diferencial , Femenino , Humanos
7.
Pediatr Dermatol ; 26(3): 351-2, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19706106

RESUMEN

Management of large congenital melanocytic nevi and neurocutaneous melanocytosis represents a difficult challenge for clinicians, due to the high risk of malignancy in both entities and the difficulty of an early diagnosis of this complication. We report a new case of neurocutaneous melanocytosis (NCM) in association with large congenital melanocytic nevi (LCMN) that illustrates a possible role of positron emission tomography in the work-up of these patients.


Asunto(s)
Sistema Nervioso Central/diagnóstico por imagen , Melanosis/diagnóstico por imagen , Síndromes Neurocutáneos/diagnóstico por imagen , Nevo Pigmentado/congénito , Tomografía de Emisión de Positrones , Preescolar , Humanos , Masculino , Melanosis/complicaciones , Síndromes Neurocutáneos/complicaciones , Nevo Pigmentado/diagnóstico por imagen , Nevo Pigmentado/patología
9.
Dermatol Online J ; 15(10): 7, 2009 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-19951625

RESUMEN

Epidermal nevus syndrome is a rare congenital sporadic neurocutaneous disorder characterized by an epidermal nevus and various developmental abnormalities of the skin, eyes, nervous, cardiovascular and urogenital systems. We describe a patient with an extensive epidermal nevus associated with various organ abnormalities, particularly polyostotic fibrous dysplasia, central nervous system lipoma, and aplasia cutis. Our patient demonstrates the polymorphic spectrum of involvement in epidermal nevus syndrome.


Asunto(s)
Displasia Ectodérmica/complicaciones , Displasia Fibrosa Poliostótica/complicaciones , Lipoma/complicaciones , Neoplasias Primarias Múltiples , Nevo/complicaciones , Neoplasias Cutáneas/complicaciones , Neoplasias de la Médula Espinal/complicaciones , Adulto , Humanos , Masculino
10.
Dermatol Online J ; 15(9): 15, 2009 Sep 15.
Artículo en Español | MEDLINE | ID: mdl-19931002

RESUMEN

The term "multiple eruptive dermatofibromas" usually refers to a clinical situation characterized by the development of between five and eight dermatofibromas during a period of up to four months. It is usually linked to immunodeficiency associated conditions as autoimmune disorders, hematologic malignancies, HIV infection, and transplants. We report three patients with Down syndrome. One patient had psoriatic arthritis under treatment with methotrexate, one had Graves-Basedow disease, and one had hypercholesterolemia. All three patients developed multiple eruptive dermatofibromas. We suggest that the immunologic disturbances associated with Down syndrome, together with other underlying conditions present in these patients, could trigger the development of cutaneous lesions.


Asunto(s)
Síndrome de Down/complicaciones , Histiocitoma Fibroso Benigno/etiología , Huésped Inmunocomprometido , Neoplasias Primarias Múltiples/etiología , Neoplasias Cutáneas/etiología , Adulto , Artritis Psoriásica/complicaciones , Artritis Psoriásica/tratamiento farmacológico , Síndrome de Down/inmunología , Femenino , Enfermedad de Graves/complicaciones , Enfermedad de Graves/inmunología , Histiocitoma Fibroso Benigno/diagnóstico , Histiocitoma Fibroso Benigno/inmunología , Histiocitoma Fibroso Benigno/patología , Histiocitoma Fibroso Benigno/cirugía , Humanos , Hipercolesterolemia/complicaciones , Inmunosupresores/efectos adversos , Inmunosupresores/uso terapéutico , Metotrexato/efectos adversos , Metotrexato/uso terapéutico , Persona de Mediana Edad , Neoplasias Primarias Múltiples/diagnóstico , Neoplasias Primarias Múltiples/inmunología , Neoplasias Primarias Múltiples/patología , Neoplasias Primarias Múltiples/cirugía , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/inmunología , Neoplasias Cutáneas/patología , Neoplasias Cutáneas/cirugía
11.
Acta Dermatovenerol Croat ; 26(1): 61-63, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29782303

RESUMEN

Clindamycin is a lincomycin-derived antibiotic useful for the treatment of anaerobic and Gram-positive aerobic bacterial infections. Cutaneous adverse reactions are usually maculopapular exanthemas, although hypersensitivity syndrome, acute generalized exanthematous pustulosis, and Stevens-Johnson syndrome have also been reported (1). We report the case of a patient with a maculopapular rash triggered by clindamycin who developed cutaneous lesions on striae distensae (SD). A 47-year-old woman was referred to our clinic for pruritic cutaneous lesions which had started 6 days earlier. Her past clinical history included hypertension, hypothyroidism, hyperuricemia, cholecystectomy, caesarean section, and endometriosis-related abdominal surgery, and she was taking levothyroxine, allopurinol, imidapril, and omeprazole. The skin rash first developed on her neck and back on the 3rd day of clindamycin oral treatment (300 mg every 6 hours), which was prescribed as antibiotic prophylaxis for a tooth implant. General malaise (but not fever) was also reported. Physical examination revealed an erythematous maculopapular eruption symmetrically distributed on the neck, abdomen, and back (Figure 1, A), with isolated lesions involving the proximal upper and lower limbs (Figure 1, B). There was a striking vertical distribution of skin lesions along the SD on the lateral sides of the abdomen (Figure 1, C). No mucosal involvement was found, and laboratory studies showed no abnormalities. Clindamycin withdrawal was followed by prescription of a course of oral deflazacort, starting at 30 mg daily and tapering down during a 9-day period. On the 5th day of treatment, the rash had almost cleared with minimal desquamation (Figure 1, D). Eight weeks after clearance of the skin rash, informed consent was obtained in order to perform an allergological evaluation of clindamycin, including prick and intradermal (ID) tests on the forearm and patch tests on the upper back (2). For patch testing, powder of the commercial capsules (Dalacin®) was diluted in petrolatum (pet.) and water (aq.), resulting in a final 1% clindamycin dilution. Parenteral clindamycin preparations were used in therapeutic concentrations for prick tests (150 mg/mL) and dilutions in saline of 1/100 and 1/10 for the ID test. Other authors have reported that these concentrations do not seem to irritate the skin (3-6). Prick and ID tests were assessed after 20 min and 24 hours, respectively. Patch tests were removed after the 2nd day, and late reactions were evaluated on day 2 and day 4. Prick and ID test results after 20 min were negative. Late results of ID tests with clindamycin (1.5 and 15 mg/mL) were positive: erythematous infiltrated papules about 7×7 mm and 18×15 mm were observed at 24 hours and lasted until the 8th day. Patch tests with clindamycin 1% in pet. and 1% in aq. were also positive (+ on day 2 and day 4). Positive late skin tests suggested delayed-type non-IgE-mediated allergic clindamycin hypersensitivity. Oral challenge tests are considered to be the gold standard to establish or exclude drug hypersensitivity. Due to the positive result of late skin test to clindamycin, oral challenge was not performed in our patient (3,5). The Koebner isomorphic phenomenon has been described in cutaneous reactions induced by drugs, such as antibiotics and chemotherapy. Chronic pressure on the skin is probably involved in the onset of skin lesions in hand-foot eruptions induced by tyrosine kinase inhibitors (sorafenib and sutinib). Solar exposure and cutaneous trauma also seem to play a role in the location of papulopustular eruptions caused by endothelial growth factor receptor inhibitors (erlotinib) (7). More frequent involvement in traumatized skin and surgical scars has been reported in the context of linear IgA bullous dermatosis and leukocytoclastic vasculitis triggered by vancomycin and cefuroxime (8). SD are produced by non-penetrating physical trauma, similar to friction or pressure. Different dermatoses can develop along SD skin lesions (like plaque psoriasis, pustular psoriasis, lichen planus, vitiligo, discoid lupus erythematosus, lupus vasculitis, urticarial vasculitis, or chronic graft-versus-host disease) (9). Bevacizumab, etretinate, and corticosteroid-induced ulcers, hyperpigmentation caused by bleomycin, and urticariform lesions triggered by diclofenac are examples of different type of drug-induced abnormalities involving SD (10). In summary, we identified clindamycin as the cause of the cutaneous reactions that occurred in our patient on the basis of the results of the skin tests and clinical history. Our findings confirmed a delayed-type hypersensitivity reaction, possibly involving a T-cell-mediated immunologic mechanism. Intradermal and patch tests were found to be useful in order to confirm the diagnosis (4,5). We did not find reports in the literature of drug-induced cutaneous eruptions along the SD as a manifestation of a Koebner phenomenon. Clinical underreporting of this phenomenon could explain the scarce literature on this cutaneous adverse reaction.


Asunto(s)
Clindamicina/efectos adversos , Erupciones por Medicamentos/etiología , Pruebas del Parche/métodos , Estrías de Distensión/etiología , Administración Oral , Biopsia con Aguja , Clindamicina/uso terapéutico , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Erupciones por Medicamentos/patología , Femenino , Estudios de Seguimiento , Humanos , Inmunohistoquímica , Persona de Mediana Edad , Medición de Riesgo , Índice de Severidad de la Enfermedad , Estrías de Distensión/patología , Privación de Tratamiento
13.
Psicooncología (Pozuelo de Alarcón) ; 17(1): 165-177, ene.-jun. 2020. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-196990

RESUMEN

Las personas con enfermedades crónicas y graves, necesitan ser escuchadas, entendidas y atendidas a su ritmo. Los profesionales necesitan herramientas sencillas y eficientes que les faciliten una buena comunicación con sus pacientes, en el menor tiempo posible. OBJETIVO: describir un protocolo sistemático de comunicación en cinco pasos. MÉTODO: Se ha diseñado un enfoque cualitativo basado en la revisión documental, que ha incluido la revisión bibliográfica y de evidencias para apoyar el análisis y poder llegar a conclusiones con la información extraída del proceso. RESULTADO: Como resultado se propone un protocolo básico de comunicación fundamentado en el counselling y en los principios de la bioética moderna, capaz de facilitar las funciones de informar, motivar la adhesión terapéutica, promover cambios de conducta, abordar situaciones de comunicación difícil y, especialmente, de tener un encuentro auténtico con el paciente y su familia. Por conclusión sin comunicación eficaz no hay encuentro, y sin encuentro, la relación clínica entre profesional y paciente se puede convertir en un intercambio de palabras vacías, de imposiciones de tratamientos, que difícilmente el paciente va a cumplir adecuadamente. Los tiempos cambian y la Medicina participativa va encontrando un lugar más adecuado en el entorno clínico


People with chronic and serious diseases, need to be heard, understood and answered at their own pace. Professionals need simple and efficient tools to have good communication with their patients, in the shortest possible time. The aim of this paper is to describe a systematic communication in five steps, protocol based on counselling and on the principles of bioethics, to facilitate the information skills, motivate therapeutic adherence, promote behavioral changes, deal with difficult situations and to have an authentic encounter with the patient and his family. It is concluded that without effective communication there is no encounter, and without encounter, the clinical relationship between professional and patient can become an exchange of empty words, of impositions of treatments, which the patient will hardly adequately comply with. Times change and participatory medicine is finding a more appropriate place in the clinical environment


Asunto(s)
Humanos , Relaciones Profesional-Paciente , Planificación Participativa , Comunicación , 25783
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA